Fullpower Technologies

Fullpower®-AI Achieves SOC 2 Type II Attestation

Retrieved on: 
Friday, November 4, 2022
Confidentiality, CPAS, System, Fullpower Technologies, American Institute, Time, Multimedia, Biotechnology, Patent, IOT, SOC 2, AICPA, SOC, Platform as a service, Review, System and Organization Controls, View, Record, Sleep, Health, B2B, Documentation, Privacy, Solution, Medical device

SANTA CRUZ, Calif., Nov. 3, 2022 /PRNewswire/ -- Fullpower-AI, the leading IoT AI-biosensing company, today announced that it has achieved SOC 2 Type II Attestation.

Key Points: 
  • SANTA CRUZ, Calif., Nov. 3, 2022 /PRNewswire/ -- Fullpower-AI, the leading IoT AI-biosensing company, today announced that it has achieved SOC 2 Type II Attestation.
  • Developed by the American Institute of CPAs (AICPA), SOC 2 (System and Organization Controls) defines criteria for managing customer data based on five "trust service principles" security, availability, processing integrity, confidentiality, and privacy.
  • Type II Attestation shows that Fullpower's processes and controls have been proven to be effective through monitoring over a period of time.
  • "We are excited to announce this significant milestone: SOC 2 Type II Certification.

Fullpower®-AI Announces the Issuance of Three New U.S. Patents Further Covering the Fullpower IoT PaaS, Smart Beds, and Sleeptracker®-AI

Retrieved on: 
Wednesday, October 5, 2022
Method, IOT, Posture, Respiration, B2B, Biotechnology, Sleep, Snoring, Platform as a service, Multimedia, Fullpower Technologies, Health, Patent, Machine learning, Environment, USPTO, Invention, Exercise, Solution, View, Construction, Pharmaceutical industry

"We are extremely pleased, as inventors and pioneers, with the continued development of the Fullpower-AI patent portfolio.

Key Points: 
  • "We are extremely pleased, as inventors and pioneers, with the continued development of the Fullpower-AI patent portfolio.
  • These new issuances continue to expand the breadth and depth of our IoT platform, Sleep, and Biosensing intellectual property portfolio," said Philippe Kahn, Chief Executive Officer of Fullpower-AI.
  • US11452916 issued 9/27/2022 - Monitoring Exercise Surface System Priority date: 1/17/2019
    A biosensing system designed to be positioned under an exercise mat.
  • Fullpower's platform is vetted and deployed as an IoT PaaS, backed by a patent portfolio of 135+ patents.

Fullpower®-AI Announces the Issuance of Three New U.S. Patents Further Covering Smart Beds, Sleeptracker®-AI, and the Fullpower®-AI PaaS Platform

Retrieved on: 
Thursday, July 14, 2022
IOT, B2B, Patent, Technology, Health, Biotechnology, Sleep, View, Multimedia, Solution, Platform as a service, Fullpower Technologies

Fullpower Technologies delivers a complete B2B IoT platform for AI-powered algorithms, remote contactless biosensing, end-to-end engineering services, and software customization in life sciences, health, and biotechnology.

Key Points: 
  • Fullpower Technologies delivers a complete B2B IoT platform for AI-powered algorithms, remote contactless biosensing, end-to-end engineering services, and software customization in life sciences, health, and biotechnology.
  • Fullpower's platform is vetted and deployed as an IoT PaaS, backed by a patent portfolio of 135+ patents.
  • Fullpower's key areas of expertise include:
    Fullpower's B2B PaaS customers are in medical solutions, remote biosensing, sleep, bedding solutions, wearable, and wellness services.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/fullpower-ai-announces-the-issu...

Fullpower®-AI, the Leader in Person/Patient-Generated Sleep Health Data (PGHD¹) with the Sleeptracker-AI® Platform, Announces New Sleep Research at World Sleep 2022

Retrieved on: 
Saturday, March 12, 2022
Congress, Comparison, AI, Fullpower Technologies, Monitoring, Health, Multimedia, Kaiser Permanente, World, Data science, Estimation, Software, COVID-19, Biotechnology, Medical device

ROME, March 12, 2022 /PRNewswire/ -- Fullpower Technologies, the leader in person/patient-generated sleep health data with the Sleeptracker-AI Platform, will announce new studies using its Sleeptracker-AI smart bed at World Sleep 2022, the 16th international meeting of the World Sleep Congress in Rome from March 11th-16th.

Key Points: 
  • ROME, March 12, 2022 /PRNewswire/ -- Fullpower Technologies, the leader in person/patient-generated sleep health data with the Sleeptracker-AI Platform, will announce new studies using its Sleeptracker-AI smart bed at World Sleep 2022, the 16th international meeting of the World Sleep Congress in Rome from March 11th-16th.
  • Dr. Clete Kushida and collaborators will present results of the following studies:
    A Comparison of Estimated Sleep-Wake Patterns Obtained from a Large U.S.
  • Sample by Home-Based Under-Mattress Monitoring Devices Before and After the Start of the COVID-19 Pandemic
    Estimated Sleep-Wake Patterns Obtained from a Large U.S.
  • www.sleeptracker.com
    About Fullpower-AI: Fullpower-AI delivers a complete B2B IoT platform for AI-powered algorithms, remote contactless biosensing together with end-to-end engineering services, and customization of software in the field of life sciences, health, and biotechnology.

Fullpower®-AI Announces New VP of Regulatory Affairs, David Shanes

Retrieved on: 
Wednesday, January 26, 2022
View, Clinical quality management system, Patent, Medical device, Compliance, Development, MDSAP, Software, VP, Certification, ECG, Regulatory affairs, Quality management system, Regulation, B2B, BS, Fullpower Technologies, Multimedia, ISO, Computer science, Quality assurance, Quality, Hispanics in the United States Naval Academy, Solution, Biotelemetry, Platform as a service, MS, Hospira, Pump, San Diego State University, LLC, CEO, Garrard Engineering and Manufacturing Company, Research, Engineering

SANTA CRUZ, Calif., Jan. 26, 2022 /PRNewswire/ -- Fullpower-AI announces David Shanes is joining Fullpower-AI as VP of Regulatory Affairs.

Key Points: 
  • SANTA CRUZ, Calif., Jan. 26, 2022 /PRNewswire/ -- Fullpower-AI announces David Shanes is joining Fullpower-AI as VP of Regulatory Affairs.
  • Mr. Shanes is responsible for managing the Regulatory and Compliance efforts for Fullpower-AI and advancing its solutions into the healthcare and medical device spaces.
  • Before that, Mr. Shanes was Vice President of Quality and Regulatory Affairs at Biocare Medical, LLC.
  • "I am very excited to have the opportunity to work with our visionary CEO, Philippe Kahn, and the stellar Fullpower-AI team," said David Shanes.

Fullpower®-AI Announces New VP of Business Development, Dr. Silvia Veronese

Retrieved on: 
Monday, January 24, 2022
Woman, Business development, Platform as a service, Research, Technology, IOT, IP, Communication Service for the Deaf, IBM, MBA, University of Pavia, CEO, University, Solution, Information management, Digital security, VP, CIO magazine, View, Fullpower Technologies, Mathematics, Artificial intelligence, Silicon, Environment, University of Management and Technology (Lahore), Multimedia, HP, Patent, Computer, B2B, Senior, Medical device, Management, AI, Platform, Thales of Miletus

SANTA CRUZ, Calif., Jan. 24, 2022 /PRNewswire/ --Fullpower-AI announced Silvia Veronese is joining Fullpower-AI as VP of Business Development.

Key Points: 
  • SANTA CRUZ, Calif., Jan. 24, 2022 /PRNewswire/ --Fullpower-AI announced Silvia Veronese is joining Fullpower-AI as VP of Business Development.
  • Before that, Dr. Veronese held executive positions at HP, where she created the function of customer success responsible for the $1B product line in digital security and information management.
  • In addition, Dr. Veronese was a research professor of mathematics at the University of Utah.
  • "Welcome, Dr. Veronese; your expertise adds exceptional talent to Fullpower-AI's stellar team," said Philippe Kahn, founder, and CEO of Fullpower-AI.

Fullpower®-AI Announces New Medical Advisory Board Member, Dr. Anil Rama, MD

Retrieved on: 
Thursday, November 4, 2021
University, View, Medical director, CEO, Family Practice (journal), Kaiser Permanente Bernard J. Tyson School of Medicine, Multimedia, Sleep, B2B, International Chinese Language Program, Solution, Platform as a service, Fullpower Technologies, Patent, Pharmaceutical industry, Medical device

SANTA CRUZ, Calif., Nov. 4, 2021 /PRNewswire/ -- Fullpower-AI announced Anil Rama had joined Fullpower-AI's advisory medical board.

Key Points: 
  • SANTA CRUZ, Calif., Nov. 4, 2021 /PRNewswire/ -- Fullpower-AI announced Anil Rama had joined Fullpower-AI's advisory medical board.
  • Anil Rama, MD is the founder of "Sleep and Brain" and serves as Adjunct Assistant Clinical Professor at the Stanford Center for Sleep Sciences and Medicine.
  • He is the recipient of the 2021 Stanford Distinguished Service Award, awarded to one clinical faculty member per year.
  • He is the former Medical Director of Kaiser Permanente's tertiary sleep medicine laboratory.

Fullpower®-AI Announces the Issuance of Eight U.S. Patents Further Covering Aspects of the Fullpower®-AI Sleeptracker®-AI and Biosensing Platforms

Retrieved on: 
Monday, June 21, 2021
Fullpower Technologies, Philippe Kahn, Trademark, Marketing, Economy of the United States, Market economics)

Patents directed to methods related to the Fullpower-AI and Sleeptracker-AI technology platforms.

Key Points: 
  • Patents directed to methods related to the Fullpower-AI and Sleeptracker-AI technology platforms.
  • The issuance of these patents is another step in the development of our robust patent portfolio," said Philippe Kahn, Chief Executive Officer of Fullpower-AI.
  • In one embodiment, the dual sleep sensor comprises two or more sensors positioned to enable the separation of motion data of a first sleeper and a second sleeper.
  • Please contact: [email protected] #AI #sleep
    Fullpower and Sleeptracker are registered trademarks of Fullpower Technologies, Inc., registered in the U.S. and other countries.

PhysIQ Expands Patent Portfolio for Artificial Intelligence Analytics in Wearables

Retrieved on: 
Wednesday, February 12, 2020
Data management, Consumer electronics, Health, Technology, Fitness & Nutrition, Software, Hardware, Network management, Business intelligence, Fullpower Technologies

PhysIQ continues to receive recognition for the novelty and value of its technology with the announcement of two new patent allowances by the US Patent & Trademark Office on its core analytics in digital medicine.

Key Points: 
  • PhysIQ continues to receive recognition for the novelty and value of its technology with the announcement of two new patent allowances by the US Patent & Trademark Office on its core analytics in digital medicine.
  • These analytics help power PhysIQs machine learning and artificial intelligence approach to providing a platform for clinical markers of health using continuous wearable sensor data.
  • The allowed patents add to an already large and venerable suite of patents that physIQ holds worldwide on its revolutionary health-monitoring technology platform.
  • PhysIQ is a company dedicated to enabling proactive care delivery models through its highly scalable cloud-based platform for personalized physiology analytics.

Fullpower Announces Issuance of 11th Sleep Monitoring Technology Patent

Retrieved on: 
Wednesday, January 22, 2020
Fullpower Technologies, Philippe Kahn, Patent, Economy of the United States

SANTA CRUZ, Calif., Jan. 22, 2020 /PRNewswire/ --Fullpower Technologies, Inc., "The sleep technology company," today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,463,300, Fullpower's 11th sleep-focused patent.

Key Points: 
  • SANTA CRUZ, Calif., Jan. 22, 2020 /PRNewswire/ --Fullpower Technologies, Inc., "The sleep technology company," today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,463,300, Fullpower's 11th sleep-focused patent.
  • The patent covers user monitoring systems for sleep technology, smart-home, and wearable device areas.
  • "This is the eleventh sleep-focused eligible U.S. patent Fullpower has been granted for our advanced sleep technology platform, and it reflects our strategy to broaden and diversify our intellectual property portfolio to obtain protection for the many innovations of the Sleeptracker AI technology platform," said Philippe Kahn, Chairman of Fullpower Technologies, Inc. "In this case, we believe our technology offers novel and potentially superior options and reflects on our deep investment in sleep technology innovation.
  • With sleep being one-third of everyone's lives, the opportunities to use Fullpower non-invasive polysomnography-level technology to improve sleep quality outcomes represent strategic opportunities.